These novel treatments, Tirzepatide , represent a groundbreaking advancement in addressing type 2 diabetes and potentially other ailments . These drugs are grouped as GLP-1 receptor agonists , https://nicolasibur608176.glifeblog.com/40021134/retatrutide-a-deep-dive-into-incretin-copyright